{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:11:46Z","timestamp":1788754306507,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,3]],"date-time":"2027-09-03T00:00:00Z","timestamp":1819929600000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.semarthrit.2026.153067","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:16:52Z","timestamp":1787552212000},"page":"153067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biologic\u2013biologic and biologic\u2013JAK inhibitor combination therapy in refractory systemic autoinflammatory diseases"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6244-9362","authenticated-orcid":false,"given":"Abdurrahman","family":"Tufan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3444-0186","authenticated-orcid":false,"given":"Tina","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-2091","authenticated-orcid":false,"given":"Patrycja","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0146-1162","authenticated-orcid":false,"given":"Natalie T.","family":"Deuitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5405-4694","authenticated-orcid":false,"given":"Christina","family":"Kozycki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6451-8173","authenticated-orcid":false,"given":"Kalpana","family":"Manthiram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1905-2375","authenticated-orcid":false,"given":"Sarah","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-4550","authenticated-orcid":false,"given":"Daniel L.","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-9416","authenticated-orcid":false,"given":"Amanda K.","family":"Ombrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2026.153067_bib0001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fimmu.2019.00101","article-title":"Biochemistry of autoinflammatory diseases: catalyzing monogenic disease","volume":"10","author":"Beck","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153067_bib0002","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41584-021-00614-1","article-title":"Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases","volume":"17","author":"Aksentijevich","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153067_bib0003","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3899\/jrheum.2023-1209","article-title":"Autoinflammatory diseases: a review","volume":"51","author":"An","year":"2024","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153067_bib0004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaci.2023.11.001","article-title":"Autoinflammatory syndromes: updates in management","volume":"153","author":"Blackstone","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153067_bib0005","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/S2665-9913(22)00108-4","article-title":"Combination therapies in rheumatoid arthritis\u2014choose your partner carefully","volume":"4","author":"Rubbert-Roth","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153067_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1283251","article-title":"Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain","volume":"14","author":"Valero-Martinez","year":"2023","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153067_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103612","article-title":"Novel therapeutic strategies for autoimmune and inflammatory rheumatic diseases","volume":"28","author":"Felten","year":"2023","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153067_bib0008","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(22)00427-7","article-title":"Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial","volume":"8","author":"Feagan","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153067_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103865","article-title":"Combination targeted therapy with two biologic\/targeted synthetic DMARDs in 1200 patients with immune mediated inflammatory diseases. A systematic literature review for current landscape in safety and efficacy","volume":"24","author":"Lignou","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153067_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5152\/EuJRheum.2022.21180","article-title":"Dual biologic therapy in patients with familial Mediterranean fever and spondyloarthritis: case-based review","volume":"10","author":"Y\u0131ld\u0131r\u0131m","year":"2023","journal-title":"Eur J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153067_bib0011","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/ard-2023-225085","article-title":"Interrupting an IFN-\u03b3-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne","volume":"83","author":"Lee","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153067_bib0012","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153067_bib0013","doi-asserted-by":"crossref","first-page":"749.1","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153067_bib0014","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153067_bib0015","first-page":"1102","volume":"74","author":"Romano","year":"2022","journal-title":"Mevalonate Kinase Defic Defic Interleukin-1 Recept Antagon, Arthritis Rheumatol,"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153067_bib0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2026.153067_bib0017","unstructured":"[Available from: https:\/\/www.nia.nih.gov\/sites\/default\/files\/2018-09\/nia-ae-and-sae-guidelines-2018.pdf?form=MG0AV3\/."},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153067_bib0018","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153067_bib0019","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jval.2021.01.005","article-title":"Use of patient and investigator global impression scales: a review of Food and Drug Administration-approved labeling, 2009 to 2019","volume":"24","author":"Gnanasakthy","year":"2021","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153067_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001227","article-title":"Systematic literature review of efficacy\/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome","volume":"6","author":"Kuemmerle-Deschner","year":"2020","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153067_bib0021","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/annrheumdis-2021-221801","volume":"81","author":"Romano","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"10.1016\/j.semarthrit.2026.153067_bib0022","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153067_bib0023","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/acr.23120","article-title":"International retrospective chart review of treatment patterns in severe familial Mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, and mevalonate kinase deficiency\/hyperimmunoglobulinemia D syndrome","volume":"69","author":"Ozen","year":"2017","journal-title":"Arthritis Care Res (Hob)"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153067_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105201","article-title":"Familial Mediterranean fever (FMF)-response to TNF-blockers used for treatment of FMF patients with concurrent inflammatory diseases","volume":"88","author":"Haj-Yahia","year":"2021","journal-title":"Jt Bone Spine"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153067_bib0025","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","article-title":"On-demand anakinra treatment is effective in mevalonate kinase deficiency","volume":"70","author":"Bodar","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153067_bib0026","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10067-018-4230-z","article-title":"On demand use of anakinra for attacks of familial Mediterranean fever (FMF)","volume":"38","author":"Babaoglu","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153067_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111967","article-title":"An \"on demand\" canakinumab regimen for treating children with Colchicine-resistant familial Mediterranean fever - A multicentre study","volume":"132","author":"Shehadeh","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153067_bib0028","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40257-024-00880-1","article-title":"Hidradenitis suppurativa: new targets and emerging treatments","volume":"25","author":"Gao","year":"2024","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153067_bib0029","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s40257-023-00789-1","article-title":"Targeting inflammation in acne: current treatments and future prospects","volume":"24","author":"Cruz","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"14","key":"10.1016\/j.semarthrit.2026.153067_bib0030","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-023-01931-3","article-title":"Pyoderma Gangrenosum: treatment options","volume":"83","author":"Dissemond","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153067_bib0031","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2018.12.003","article-title":"Safety of combination therapy with two bDMARDs in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"49","author":"Boleto","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153067_bib0032","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10875-024-01719-4","article-title":"Monitoring of adverse events and safety in autoinflammatory diseases: real-life data from the Eurofever registry","volume":"44","author":"Vyzhga","year":"2024","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153067_bib0033","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/art.20221","article-title":"Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate","volume":"50","author":"Genovese","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153067_bib0034","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard-2023-225179","article-title":"Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types","volume":"83","author":"Tchitchek","year":"2024","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:02:35Z","timestamp":1788753755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226001575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S0049017226001575"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153067","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologic\u2013biologic and biologic\u2013JAK inhibitor combination therapy in refractory systemic autoinflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153067"}}